Pre-first-line chemotherapy risk stratification for overall survival in advanced urothelial carcinoma in sequential therapy era.

导出 LinkOut

翻译打印收藏纠错

作者： Tetsuya,Shindo ^[1] ; Kohei,Hashimoto ^[2] ; Keiko,Fujino ^[1] ; Atsushi,Takahashi ^[3] ; Hiroshi,Hotta ^[4] ; Toshihiro,Maeda ^[5] ; Yasuharu,Kunishima ^[6] ; Fumimasa,Fukuta ^[7] ; Naoki,Ito ^[8] ; Atsushi,Wanifuchi ^[9] ; Ryuichi,Kato ^[10] ; Manabu,Okada ^[11] ; Masanori,Matsukawa ^[12] ; Hiroki,Horita ^[13] ; Akio,Takayanagi ^[14] ; Ko,Kobayashi ^[1] ; Toshiaki,Tanaka ^[1] ; Naoya,Masumori ^[1]

作者单位： Department of Urology, Sapporo Medical University School of Medicine, S1, W16, Chuo-ku, Sapporo, 060-8543, Japan. ^[1] Department of Urology, Sapporo Medical University School of Medicine, S1, W16, Chuo-ku, Sapporo, 060-8543, Japan. kohei@cj9.so-net.ne.jp. ^[2] Department of Urology, Hakodate Goryoukaku Hospital, Hakodate, Japan. ^[3] Department of Urology, Japanese Red Cross Asahikawa Hospital, Asahikawa, Japan. ^[4] Department of Urology, Oji General Hospital, Tomakomai, Japan. ^[5] Department of Urology, Sunagawa City Medical Center, Sunagawa, Japan. ^[6] Department of Urology, Steel Memorial Muroran Hospital, Muroran, Japan. ^[7] Department of Urology, NTT East Medical Center Sapporo, Sapporo, Japan. ^[8] Department of Urology, Japanese Red Cross Kushiro Hospital, Kushiro, Japan. ^[9] Department of Urology, Muroran City General Hospital, Muroran, Japan. ^[10] Department of Urology, Obihiro Kyokai Hospital, Obihiro, Japan. ^[11] Department of Urology, Takikawa Municipal Hospital, Takikawa, Japan. ^[12] Department of Urology, Saiseikai Otaru Hospital, Otaru, Japan. ^[13] Department of Urology, Japan Community Health Care Organization Hokkaido Hospital, Sapporo, Japan. ^[14]

关键词 Chemotherapy Immune checkpoint inhibitor Overall survival Sequential therapy Urothelial carcinoma